Deutsche Bank’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
PCM
SAM
QPW
AA
Deutsche Bank's EWTX Position: Q2 2026 in Review
Deutsche Bank increased its Edgewise Therapeutics (EWTX) stake by 10% in Q2 2026, buying an estimated $797K and bringing the position to 244,995 shares worth $9.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1064.
Deutsche Bank first reported a position in EWTX in Q2 2021 and has held it in 21 quarters since. 64 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.
- Deutsche Bank held 244,995 shares of Edgewise Therapeutics worth $9.95M as of Q2 2026.
- Deutsche Bank bought 23,127 Edgewise Therapeutics shares in Q2 2026, an estimated $797K.
- Edgewise Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1064 holding.
- Deutsche Bank first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 21 quarters since.
- 64 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.